Beware the Limits of Implied Volatility
For example, drug firm Adolor (ADLR) saw the implied volatility on its August front-month options surge from 50% to more than 115% in the five days prior to the Food and Drug Administration's scheduled July 25 hearing regarding the company's drug Entereg. This translates into expectations for a 20%, or $2, price change, either up or down, within a four-week period.
One quick way to gauge the expected move is to use a thumbnail calculation based on the price of the at-the-money straddle. With Adolor trading at $10 per share, the August $10 straddle (the total cost to purchase the $10 put and $10 call) was priced around $2. After the FDA released a letter providing for "initial approval" of Entereg, the immediate reaction saw shares jumping to an intraday high of $12.20. Sounds like a 20% move.
But as traders delved further into the full release, which included a statement that additional proof of the drug's effectiveness would be required before the company would be allowed to market the drug, the stock reversed course and ended up back at $10 per share.
This is a fine example of options accurately pricing in an imminent move, but it also highlights the nondirectional nature of implied volatility and the difficulty of realizing a profit even if what has been predicted comes to pass.
Options markets have been equally prescient in anticipating earnings causing a price movement with everything from Caterpillar (CAT) to Amazon (AMZN) seeing the implied volatility on their options ratchet up ahead of earnings to a level that fairly accurately predicted the resulting move. Looking ahead, keep an eye on Pozen (POZN). The drug company reported earnings on Thursday, basically met all expectations and saw its shares remain unchanged near $8.50 per share. Typically, following such an earnings report, the related options would undergo a contraction in pricing as the implied volatility level declined. But the implied volatility in Pozen's options actually crept higher, to a very rich 108% level.Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV